112 related articles for article (PubMed ID: 17937839)
21. Emerging technologies for point-of-care genetic testing.
Dobson MG; Galvin P; Barton DE
Expert Rev Mol Diagn; 2007 Jul; 7(4):359-70. PubMed ID: 17620045
[TBL] [Abstract][Full Text] [Related]
22. History of health technology assessment: Spain.
Sampietro-Colom L; Asua J; Briones E; Gol J;
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():163-73. PubMed ID: 19538814
[TBL] [Abstract][Full Text] [Related]
23. Michigan genetics plan: a report on the needs assessment process.
Beene-Harris R; Bach JV
Health Promot Pract; 2009 Apr; 10(2):201-9. PubMed ID: 19372281
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the quality of mini-HTA.
Kidholm K; Ehlers L; Korsbek L; Kjaerby R; Beck M
Int J Technol Assess Health Care; 2009 Jan; 25(1):42-8. PubMed ID: 19126250
[TBL] [Abstract][Full Text] [Related]
25. Public health policy decisions on medical innovations: what role can early economic evaluation play?
Hartz S; John J
Health Policy; 2009 Feb; 89(2):184-92. PubMed ID: 18619704
[TBL] [Abstract][Full Text] [Related]
26. Using best-worst scaling in horizon scanning for hepatocellular carcinoma technologies.
Gallego G; Bridges JF; Flynn T; Blauvelt BM; Niessen LW
Int J Technol Assess Health Care; 2012 Jul; 28(3):339-46. PubMed ID: 22980714
[TBL] [Abstract][Full Text] [Related]
27. Ethical evaluation in health technology assessment reports: an eclectic approach.
Autti-Rämö I; Mäkelä M
Int J Technol Assess Health Care; 2007; 23(1):1-8. PubMed ID: 17234010
[TBL] [Abstract][Full Text] [Related]
28. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.
Sroczynski G; Esteban E; Conrads-Frank A; Schwarzer R; Mühlberger N; Wright D; Zeuzem S; Siebert U
Eur J Public Health; 2009 Jun; 19(3):245-53. PubMed ID: 19196737
[TBL] [Abstract][Full Text] [Related]
29. Information service on new and emerging health technologies: identification and prioritization processes for a European union-wide newsletter.
Wild C; Simpson S; Douw K; Geiger-Gritsch S; Mathis S; Langer T
Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():48-55. PubMed ID: 20030891
[TBL] [Abstract][Full Text] [Related]
30. Rapid reviews versus full systematic reviews: an inventory of current methods and practice in health technology assessment.
Watt A; Cameron A; Sturm L; Lathlean T; Babidge W; Blamey S; Facey K; Hailey D; Norderhaug I; Maddern G
Int J Technol Assess Health Care; 2008; 24(2):133-9. PubMed ID: 18400114
[TBL] [Abstract][Full Text] [Related]
31. The development of health technology assessment in Brazil.
Banta D; Almeida RT
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():255-9. PubMed ID: 19538816
[TBL] [Abstract][Full Text] [Related]
32. [Possibilities and limitations of genetic research; an advisory report from the Advisory Council on Health Research].
Grobbee DE
Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1571-3. PubMed ID: 12224478
[TBL] [Abstract][Full Text] [Related]
33. Health technology management in Israel: HTA in action.
Shemer J; Shani M; Tamir O; Siebzehner MI
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():134-9. PubMed ID: 19527535
[TBL] [Abstract][Full Text] [Related]
34. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
Rubinstein A; Pichon-Riviere A; Augustovski F
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
[TBL] [Abstract][Full Text] [Related]
35. Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.
Retèl VP; Bueno-de-Mesquita JM; Hummel MJ; van de Vijver MJ; Douma KF; Karsenberg K; van Dam FS; van Krimpen C; Bellot FE; Roumen RM; Linn SC; van Harten WH
Int J Technol Assess Health Care; 2009 Jan; 25(1):73-83. PubMed ID: 19126254
[TBL] [Abstract][Full Text] [Related]
36. Defining products for a new health technology assessment agency in Madrid, Spain: a survey of decision makers.
Andradas E; Blasco JA; Valentín B; López-Pedraza MJ; Gracia FJ
Int J Technol Assess Health Care; 2008; 24(1):60-9. PubMed ID: 18218170
[TBL] [Abstract][Full Text] [Related]
37. A determination of topics for health technology assessment in Thailand: making decision makers involved.
Lertpitakpong C; Chaikledkaew U; Thavorncharoensap M; Tantivess S; Praditsitthikorn N; Youngkong S; Yothasamut J; Udomsuk K; Sinthitichai K; Teerawattananon Y
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S100-9. PubMed ID: 19253492
[TBL] [Abstract][Full Text] [Related]
38. Development of health technology assessment in Lithuania.
Danguole J
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():140-2. PubMed ID: 19575824
[TBL] [Abstract][Full Text] [Related]
39. Scanning the horizon of obsolete technologies: possible sources for their identification.
Ibargoyen-Roteta N; Gutierrez-Ibarluzea I; Asua J; Benguria-Arrate G; Galnares-Cordero L
Int J Technol Assess Health Care; 2009 Jul; 25(3):249-54. PubMed ID: 19619342
[TBL] [Abstract][Full Text] [Related]
40. Genetic screening in Europe.
Javaher P; Nyoungui E; Kääriäinen H; Kristoffersson U; Nippert I; Sequeiros J; Schmidtke J
Public Health Genomics; 2010; 13(7-8):524-37. PubMed ID: 20203479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
